Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 14, 2005; 11(14): 2109-2116
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2109
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2109
U68233 | Nuclear receptor subfamily 1, group H, member 4** | NR1H4 | 16.80±0.65 | |
AF035284 | Fatty acid desaturase 1 | FADS1 | U1 | 16.82±0.92 |
X04898 | Apolipoprotein A-II | APOA2 | U1 | 16.96±2.01 |
AL031295 | Lysophospholipase II | LYPLA2 | P3 | 17.01±0.19 |
AL031295 | 3-Hydroxymethyl-3-methylglutaryl-Coenzyme A lyase (hydroxymethylglutaricaciduria) | HMGCL | 17.01±0.19 | |
M55150 | Fumarylacetoacetate hydrolase (fumarylacetoacetase) | FAH | 17.41±2.04 | |
M31210 | Endothelial differentiation, sphingolipid G-protein-coupled receptor, 1 | EDG1 | 17.56±0.62 | |
BE395256 | Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) | LSS | 17.63±1.71 | |
NM_000483 | Apolipoprotein C-II | APOC2 | U1 | 17.71±1.70 |
L76465 | Hydroxyprostaglandin dehydrogenase 15-(NAD) | HPGD | 17.86±0.79 | |
S68287 | Aldo-keto reductase family 1, member C4 (chlordecone reductase 3-alpha hydroxysteroid dehydrogenase, type I dihydrodiol dehydrogenase 4) | AKR1C4 | P3 | 18.11±2.89 |
M54927 | Proteolipid protein 1 (Pelizaeus-Merzbacher disease, spastic paraplegia 2, uncomplicated) | PLP1 | P3 | 18.21±1.67 |
BE714757 | Lipase A, lysosomal acid, cholesterol esterase (Wolman’s disease) | LIPA | 18.26±2.02 | |
AJ238243 | Phospholipase A2-activating protein | PLAA | 18.73±3.07 | |
AF077820 | Low density lipoprotein receptor-related protein 5 | LRP5 | 18.98±2.79 | |
AL031778 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 | APOBEC2 | P3 | 19.21±3.45 |
AC004770 | Fatty acid desaturase 1 | FADS1 | U1 | 19.22±9.65 |
AC004770 | Fatty acid desaturase 3 | FADS3 | 19.22±9.65 | |
AA280051 | Fatty acid binding protein 1, liver | FABP1 | U1 | 19.81±3.80 |
X67698 | Niemann–Pick disease, type C2 gene | NPC2 | 20.53±1.84 | |
AL049748 | Apolipoprotein L, 5 | APOL5 | 20.61±0.01 | |
X51416 | Estrogen-related receptor alpha | ESRRA | 20.63±1.82 | |
AF065215 | Phospholipase A2, group IVB (cytosolic) | PLA2G4B | P3 | 20.71±3.25 |
AB006746 | Phospholipid scramblase 1 | PLSCR1 | U1 | 21.33±0.62 |
M59979 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | PTGS1 | P3 | 21.55±0.74 |
X02162 | Apolipoprotein A-I | APOA1 | U1 | 21.70±0.75 |
AF079167 | Oxidised low density lipoprotein (lectin-like) receptor 1 | OLR1 | P3 | 22.12±7.75 |
U55764 | Sulfotransferase, estrogen-preferring | STE | 22.15±2.72 | |
J03459 | Leukotriene A4 hydrolase | LTA4H | 22.32±4.28 | |
U03090 | Phospholipase A2, group V | PLA2G5 | P3 | 22.88±2.74 |
M76665 | Hydroxysteroid (11-beta) dehydrogenase 1 | HSD11B1 | P3 | 22.98±3.71 |
NM_016108 | Androgen induced protein | AIG-1 | P3 | 23.02±3.33 |
AV651650 | ESTs, highly similar to AF237982 1 oxysterol 7 alpha-hydroxylase [H.sapiens] | 23.62±0.57 | ||
U11313 | Sterol carrier protein 22 | SCP2 | U1 | 23.92±0.18 |
NM_001645 | Apolipoprotein C-I | APOC1 | U1 | 25.02±12.59 |
X54741 | Cytochrome P450, subfamily XIB (steroid 11-beta-hydroxylase), polypeptide 2 | CYP11B2 | 25.13±3.81 | |
X01388 | Apolipoprotein C-III | APOC3 | 25.17±4.82 | |
R98624 | Bile acid Coenzyme A: amino acid N-acyltransferase (glycine N-choloyltransferase) | BAAT | P3 | 25.26±16.74 |
U93305 | Proteolipid protein 2 (colonic epithelium-enriched) | PLP2 | P3 | 25.41±2.44 |
U67963 | Lysophospholipase-like | HU-K5 | 26.75±5.28 | |
D86096 | Prostaglandin E receptor 3 (subtype EP3) | PTGER3 | P3 | 26.79±0.19 |
AL022398 | Hydroxysteroid (11-beta) dehydrogenase 1 | HSD11B1 | 26.82±8.70 | |
X76488 | Lipase A, lysosomal acid, cholesterol esterase (Wolman’s disease) | LIPA | 27.10±11.84 | |
AF019225 | Apolipoprotein L | APOL1 | U1 | 28.12±1.76 |
AL034374 | Homolog of yeast long chain polyunsaturated fatty acid elongation enzyme 2 | HELO1 | 28.76±4.09 | |
AI675602 | EST, moderately similar to I65981 fatty acid omega-hydroxylase [H.sapiens] | 28.85±13.77 | ||
U89281 | Oxidative 3 alpha hydroxysteroid dehydrogenase; retinol dehydrogenase; 3-hydroxysteroid epimerase | RODH | 29.09±7.19 | |
AL022318 | Phorbolin (similar to apolipoprotein B mRNA editing protein) | DJ742C19.2 | 29.26±5.26 | |
X07228 | Lipase, hepatic | LIPC | P3 | 30.57±4.34 |
AL031230 | Glycosylphosphatidylinositol specific phospholipase D1 | GPLD1 | 30.88±1.21 | |
AA128778 | Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | TFPI | 32.76±0.09 | |
Z99390 | L-3-hydroxyacyl-Coenzyme A dehydrogenase, short chain | HADHSC | 33.87±0.98 | |
AF002020 | Niemann–Pick disease, type C12 | NPC1 | 34.88±12.12 | |
X55764 | Cytochrome P450, subfamily XIB (steroid 11-beta-hydroxylase), polypeptide 1 | CYP11B1 | 34.95±1.61 | |
L34081 | Bile acid Coenzyme A: amino acid N-acyltransferase (glycine N-choloyltransferase) | BAAT | P3 | 37.8±3.91 |
AF002668 | Degenerative spermatocyte (homolog Drosophila lipid desaturase) | DEGS | 37.93±4.50 | |
AF034544 | 7-Dehydrocholesterol reductase | DHCR7 | 38.05±2.80 | |
D82073 | Prostaglandin D2 synthase, hematopoietic | PGDS | 38.83±13.58 | |
Z37986 | Emopamil-binding protein (sterol isomerase) | EBP | 41.25±12.24 | |
L21934 | Sterol O-acyltransferase (acyl-Coenzyme A: cholesterol acyltransferase) 1 | SOAT1 | P3 | 44.08±1.76 |
L21934 | Sterol O-acyltransferase (acyl-Coenzyme A: cholesterol acyltransferase) 12 | SOAT1 | P3 | 44.08±1.76 |
- Citation: Yuan ZB, Han TQ, Jiang ZY, Fei J, Zhang Y, Qin J, Tian ZJ, Shang J, Jiang ZH, Cai XX, Jiang Y, Zhang SD, Jin G. Expression profiling suggests a regulatory role of gallbladder in lipid homeostasis. World J Gastroenterol 2005; 11(14): 2109-2116
- URL: https://www.wjgnet.com/1007-9327/full/v11/i14/2109.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i14.2109